HT-Advance
Company

HT-Advance

Public Health The Major Causes of Treatment Failure in Ht. 31 employees
Employees
31

HT-Advance Overview

Headquarters
The Major Causes of Treatment Failure in Ht.
Website
ht-advance.eu
Industry
Public Health
Employees
31
Founded
2023
NAICS
Administration of Public Health Programs

About HT-Advance

The objective of this EU-funded research project is to apply multi-omics (MOMICS) stratification biomarkers directed at patients with arterial hypertension (HT), in order to develop and validate targeted personalized treatment strategies. The HT-Advance approach will address the major causes of treatment failure in HT. Funded by the European Union

Compare Similar Companies to HT-Advance